A.forall Group

Active Public limited companyfounded 2017active for 8 yearsMarie Curiesquare 50, 1070 AnderlechtKBO/BCE: BE 0684.777.042 #2 company by total assets in Anderlecht, Administrative and support services sector

Heads the group A.forall Group 16 companies in 4 countries

See the group

A.forall Group

Follow Report Compare

Holdings

own 2024 accounts, the bar shows equity in euros

This companyA.forall Group2 holdings, 1 country 2024 accounts

Belgium 2 Equity Result

BE A.forall development €37.6m result -€1.7m
BE Medigroup €23.7m result -€201,774

Source: list of holdings in its own 2024 accounts. Every holding stands with its own latest accounts.

Heads the group A.forall Group Group, risk and exposure

The LEI register names no parent.

At the same address

Marie Curiesquare 50, 1070 Anderlecht · 9 other companies

A.forall Development registered office since 15-07-2010 · founded in 2010 · group A.forall Group	11 FTE (2025) 0827.869.165
PI PHARMA establishment since 01-01-2011 · founded in 2006 · negative equity (2025) · group A.forall Group	12 FTE (2025) 0883.315.652
MEDIGROUP registered office since 18-06-2010 · founded in 2010 · group A.forall Group	14 FTE (2025) 0826.773.857
FCR MEDIA BELGIUM establishment since 01-07-2016 · founded in 2008 · negative equity (2025)	163 FTE (2025) 0807.677.428
NEOGEN registered office since 07-01-1992 · founded in 1991 · group A.forall Group	total assets €17.8m (2025) 0445.922.856
S.A. ISTA N.V. registered office since 31-07-2006 · founded in 1978	54 FTE (2025) 0417.918.263
IMPEXECO establishment since 01-04-2013 · founded in 2002 · group A.forall Group	turnover €13.3m (2025) 0477.407.472
Maatschap Eden registered office since 20-12-2017	founded in 2017 0730.754.250
Openbaar Centrum voor Maatschappelijk Welzijn van Anderlecht establishment since 01-01-2011	founded in 1968 0212.346.856

Earlier ties

Dance Hold via SVR INVEST, at A.forall Group, last mentioned in 2018 · Director · deed of 21-08-2020 founded in 2007 · negative equity (2025)	total assets €5.9m (2025)
SILVERLINE DEVELOPMENT via SVR INVEST, at A.forall Group, last mentioned in 2018 · Director (not named in the articles) · deed of 28-11-2023 founded in 2018 · negative equity (2025)	total assets €2.4m (2025)
ARYSTA LIFESCIENCE BENELUX via Themtis, no longer at ARYSTA LIFESCIENCE BENELUX · Manager · deed of 17-04-2015 founded in 2005 · group UPL LIMITED	33 FTE (2026)
Hyloris Pharmaceuticals via Jacobsen Management (at A.forall Group, last mentioned in 2020), SVR INVEST (at A.forall Group, last mentioned in 2018) and SVR Management (at A.forall Group, last mentioned in 2018) · deeds of 17-12-2025, 18-02-2020 and 08-06-2017 founded in 2017	turnover €3.8m (2025)
Arysta LifeScience Ougrée Production via Themtis, no longer at Arysta LifeScience Ougrée Production · Manager · deed of 15-05-2015 founded in 1945 · group UPL LIMITED	96 FTE (2026)
SILVERLINE PROPERTIES via SVR INVEST, at A.forall Group, last mentioned in 2018 · Director (not named in the articles) · deed of 28-11-2023 founded in 2017	total assets €20.7m (2025)

Show 3 more earlier ties

Hyloris Developments via SVR Management, at A.forall Group, last mentioned in 2018 · Day-to-day manager · deed of 06-07-2020 founded in 2013	12 FTE (2025)
DERMAX via SVR Management, at A.forall Group, last mentioned in 2018 · Day-to-day manager · deed of 17-07-2020 founded in 2016	turnover €1.6m (2025)
Hyloris via SVR Management, at A.forall Group, last mentioned in 2018 · Managing director · deed of 06-07-2020 founded in 2017	turnover €384,852 (2025)

Holdings and subsidiaries

2 in the list of holdings, 1 from the LEI register · 14 subsidiaries, including indirect ones

BETA ACTIVE PI PHARMA LIMITEDIEsubsidiary
SourceLEI register

consolidated

Share, source and own figures per holding (2)

Source for every holding own accounts 2024

A.forall Developmentsubsidiary
Equity €37.6m Loss of €1.7m in 2025 (profit of €12.3m in 2024)

100%
MEDIGROUPsubsidiary
Equity €23.7m Loss of €201,774 in 2025 (profit of €3.9m in 2024) Checked score 91

100%

All subsidiaries, including indirect ones 14

A.forall Group or one of its subsidiaries holds more than half of the shares of these companies. A company it consolidates per the LEI register is listed too.

A.forall Development 100%5 subsidiaries
- A.forall Access Ltd.IE 100%
- Generic Pharma International LTD.IE 100%
- Generic Specialty Pharma LTD.IE 100%
- Milla Pharmaceuticals Inc.US 100%
- NEOGEN 100%
MEDIGROUP 100%6 subsidiaries
- Beta Active PI Pharma LtdIE 100%
- ECO.PHARMA.SUPPLY 100%1 subsidiary
  - ECO.PHARMA.SUPPLY B.V.NL 100%
- ECOPHARMASUPPLY DISTRIBUTION 100%
- IMPEXECO 100%
- PI PHARMA 100%
BETA ACTIVE PI PHARMA LIMITEDIE consolidated

Holdings through the years 2018 to 2024

Holdings through the years
Name	2018	2020	2021	2022	2023	2024
A.forall Development 2018 to 2024: 100%	100%
MEDIGROUP 2020 to 2024: 100%		100%

Source: list of holdings in its own accounts

Connections & network

3 connected companies

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet

Linked via shared directors

FYTEKO

via Themtis · Director · deed of 16-07-2020

Founded in 2014 · 16 FTE (2025)

→

ECO.PHARMA.SUPPLY

via Themtis · Director · deed of 28-04-2022

Founded in 2013 · 6.8 FTE (2025) · group A.forall Group

→

ECOPHARMASUPPLY DISTRIBUTION

via Themtis · Director · deed of 10-10-2022

Founded in 1994 · total assets €620,829 (2025) · group A.forall Group

→